Promius Pharma™, Specialty Business

Promius Pharma™, Dr. Reddy’s Specialty Business, has a strategy to build a branded, innovation-based business consisting of differentiated, proprietary products that meet unmet medical needs and that are aligned within global therapeutic areas.

Initial global therapeutic area focus is on dermatology, two therapeutic areas that enable commercial success with relatively smaller, targeted sales and marketing efforts and best leverage our internal assets. A key component of the Promius Pharma strategy includes a strong, targeted business development effort (in-licensing, co-development, and acquisitions of products and companies) to accelerate market entry, achieve critical mass, and build a sustainable business.

Our assets include proprietary technologies that were acquired from Trigenesis (a company acquired in the year 2004), internally developed proprietary drug delivery platforms (e.g., microspheres), and current internal compounds under preclinical and clinical development (e.g., biologics, NCEs, etc).